Cart
sales@molnova.com
Oleoylestrone
CAS No. 180003-17-2
Oleoylestrone( —— )
Catalog No. M34356 CAS No. 180003-17-2
Oleoylestrone (MP-101) is present in plasma and adipose tissue, has potential antioxidant effects, induces loss of body fat in rats, and can be used for weight loss.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | Get Quote |
|
| 5MG | 686 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOleoylestrone
-
NoteResearch use only, not for human use.
-
Brief DescriptionOleoylestrone (MP-101) is present in plasma and adipose tissue, has potential antioxidant effects, induces loss of body fat in rats, and can be used for weight loss.
-
DescriptionOleoylestrone (MP-101) is present in plasma and adipose tissue, has potential antioxidant effects, induces loss of body fat in rats, and can be used for weight loss.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetAntioxidant
-
RecptorAntioxidant
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number180003-17-2
-
Formula Weight534.81
-
Molecular FormulaC36H54O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@@]12[C@]([C@]3([C@@](C=4C(CC3)=CC(OC(CCCCCCC/C=C\CCCCCCCC)=O)=CC4)(CC1)[H])[H])(CCC2=O)[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Dimethylacrylshikoni...
Dimethylacrylshikonin is a promising agent for developing an improved strategy for radiotherapy against tumors.
-
Beta-Lapachone
Beta-Lapachone is a specific DNA topoisomerase I inhibitor, and no inhibitory activities against DNA topoisomerase II or ligase.
-
Theaflavin 33'-digal...
8-Gingerol (TFDG) a major polyphenol found in black tea is an inducer of oxidative stress which has anti-inflammatory and cancer chemopreventive actions it reduces tumor angiogenesis by downregulating HIF-1αand VEGF.
